BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 6707945)

  • 1. Cadmium-Metallothionein nephropathy: relationships between ultrastructural/biochemical alterations and intracellular cadmium binding.
    Squibb KS; Pritchard JB; Fowler BA
    J Pharmacol Exp Ther; 1984 Apr; 229(1):311-21. PubMed ID: 6707945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotoxicity of cadmium-metallothionein: protection by zinc and role of glutathione.
    Tang W; Sadovic S; Shaikh ZA
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):276-82. PubMed ID: 9707504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepancy between the nephrotoxic potencies of cadmium-metallothionein and cadmium chloride and the renal concentration of cadmium in the proximal convoluted tubules.
    Dorian C; Gattone VH; Klaassen CD
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):161-8. PubMed ID: 7839364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats.
    Liu J; Habeebu SS; Liu Y; Klaassen CD
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):48-58. PubMed ID: 9875299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal toxicity of cadmium-metallothionein and enzymuria in rats.
    Suzuki CA; Cherian MG
    J Pharmacol Exp Ther; 1987 Jan; 240(1):314-9. PubMed ID: 2879904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular metabolism and effects of circulating cadmium-metallothionein in the kidney.
    Squibb KS; Fowler BA
    Environ Health Perspect; 1984 Mar; 54():31-5. PubMed ID: 6734565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallothionein plays less of a protective role in cadmium-metallothionein-induced nephrotoxicity than in cadmium chloride-induced hepatotoxicity.
    Liu J; Liu Y; Michalska AE; Choo KH; Klaassen CD
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1216-23. PubMed ID: 8786554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotoxicity of repeated injections of cadmium-metallothionein in rats.
    Wang XP; Chan HM; Goyer RA; Cherian MG
    Toxicol Appl Pharmacol; 1993 Mar; 119(1):11-6. PubMed ID: 8470114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection by zinc-metallothionein (ZnMT) against cadmium-metallothionein-induced nephrotoxicity.
    Dorian C; Klaassen CD
    Fundam Appl Toxicol; 1995 Jun; 26(1):99-106. PubMed ID: 7657068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of cadmium-metallothionein-induced nephrotoxicity: relationship to altered renal calcium metabolism.
    Fowler BA; Goering PL; Squibb KS
    Experientia Suppl; 1987; 52():661-8. PubMed ID: 2822468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nephrotoxicity of intravenously administered cadmium-metallothionein: effect of dose, mode of administration, and preexisting renal cadmium burden.
    Vestergaard P; Shaikh ZA
    Toxicol Appl Pharmacol; 1994 Jun; 126(2):240-7. PubMed ID: 8209377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of MT-null mice to chronic CdCl2-induced nephrotoxicity indicates that renal injury is not mediated by the CdMT complex.
    Liu J; Liu Y; Habeebu SS; Klaassen CD
    Toxicol Sci; 1998 Nov; 46(1):197-203. PubMed ID: 9928683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of metallothionein in cadmium traffic and toxicity in kidneys and other mammalian organs.
    Sabolić I; Breljak D; Skarica M; Herak-Kramberger CM
    Biometals; 2010 Oct; 23(5):897-926. PubMed ID: 20549307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ultrastructural techniques in understanding mechanisms of metal-induced nephrotoxicity.
    Fowler BA
    Fed Proc; 1983 Oct; 42(13):2957-64. PubMed ID: 6617893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cadmium-metallothionein nephrotoxicity in the rat: transient calcuria and proteinuria.
    Jin TY; Leffler P; Nordberg GF
    Toxicology; 1987 Sep; 45(3):307-17. PubMed ID: 3629613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal accumulation of cadmium and nephropathy following long-term administration of cadmium-metallothionein.
    Min KS; Onosaka S; Tanaka K
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):102-9. PubMed ID: 8917681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multivariate study of protective effects of Zn and Cu against nephrotoxicity induced by cadmium metallothionein in rats.
    Liu XY; Jin TY; Nordberg GF; Rännar S; Sjöström M; Zhou Y
    Toxicol Appl Pharmacol; 1992 Jun; 114(2):239-45. PubMed ID: 1609416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cadmium, copper, and zinc excretion and their binding to metallothionein in urine of cadmium exposed rats.
    Suzuki Y; Yoshikawa H
    J Toxicol Environ Health; 1981 Sep; 8(3):479-87. PubMed ID: 7345169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of cadmium to alcohol dehydrogenase in the liver before induction of metallothionein.
    Suzuki KT; Sunaga H; Yamane Y; Aoki Y
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):223-36. PubMed ID: 1811283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metallothionein protects against the nephrotoxicity produced by chronic CdMT exposure.
    Liu Y; Liu J; Habeebu SS; Klaassen CD
    Toxicol Sci; 1999 Aug; 50(2):221-7. PubMed ID: 10478858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.